Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant
| Autor: | J. M. W. M. Merkus, A.M. van Heusden |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Adult
Antifungal Pediatrics medicine.medical_specialty Antifungal Agents medicine.drug_class Itraconazole Therapeutic treatment medicine.medical_treatment Administration Oral Vaginal candidosis Drug Administration Schedule Recurrence medicine Humans Candidiasis Vulvovaginal Menstrual Cycle Mycosis Chemotherapy business.industry Obstetrics and Gynecology Middle Aged medicine.disease Surgery Ketoconazole medicine.anatomical_structure Reproductive Medicine Treatment Schedule Chronic Disease Vagina Female business medicine.drug |
| Zdroj: | European Journal of Obstetrics & Gynecology and Reproductive Biology. 35:75-83 |
| ISSN: | 0301-2115 |
| DOI: | 10.1016/0028-2243(90)90145-q |
| Popis: | Research into the pathogenesis and treatment of chronic recurrent candidosis vaginalis did not come up with a clear answer of curing this phenomenon. In this investigation, data are presented of a therapy with a new antifungal agent, itraconazole. After a therapeutic treatment course, 17 patients received a prophylaxis for CRCV over 6 months. The treatment schedule for prophylaxis consisted of 4 capsules of 50 mg itraconazole on day 5 and 6 of the menstrual cycle. Eleven remained symptom-free in this period. Although there is no explanation for recurrence in most cases of CRCV, intermittent treatment schedules can be used to treat but not to cure these patients. Data of this investigation and data mentioned in the literature prove the necessity to discriminate between a symptomatic and a mycological cure. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|